ADVFN - Advanced Financial Network.
HOME» NYSE » A » ABT Stock Price » ABT Stock News

Abbott Labs Share News

 Abbott Laboratories Stock Price
ABT Stock Price
 Abbott Laboratories Stock Chart
ABT Stock Chart
 Abbott Laboratories Stock News
ABT Stock News
 Abbott Laboratories Company Information
ABT Company Information
 Abbott Laboratories Stock Trades
ABT Stock Trades

Abbott India Names Rehan Khan Managing Director

BANGALORE -(Dow Jones)- Abbott India Ltd. (500488.BY) said Rehan Khan has been appointed as the company's managing director, effective Thursday. Khan is currently general manager and country head of Abbott Nutrition, India, a position he has held since 2009, the Indian unit of Abbott Laboratories (ABT) said in a statement. Khan replaces Vivek Mohan, who has been named senior director, global integrated health, established pharmaceuticals division, at Abbott. Mohan will report to Michael Warmuth, senior vice president, established pharmaceuticals division, at Abbott. -By Rumman Ahmed, Dow Jones Newswires; 91-9845104173;

Stock News for Abbott Labs (ABT)
07/06/201513:06:06Teva May Raise Offer for Mylan to Range of $86 to $88 a Share...
07/02/201517:08:15Statement of Changes in Beneficial Ownership (4)
07/02/201517:07:46Statement of Changes in Beneficial Ownership (4)
07/02/201517:07:22Statement of Changes in Beneficial Ownership (4)
07/02/201517:06:55Statement of Changes in Beneficial Ownership (4)
07/02/201517:06:03Statement of Changes in Beneficial Ownership (4)
07/02/201517:05:36Statement of Changes in Beneficial Ownership (4)
07/02/201517:05:10Statement of Changes in Beneficial Ownership (4)
07/01/201509:00:00Abbott Hosts Conference Call for Second-Quarter Earnings
06/29/201508:07:03Better Dividend Stock: AbbVie or Johnson & Johnson?
06/26/201513:17:47Annual Report of Employee Stock Plans (11-k)
06/16/201518:22:46Statement of Changes in Beneficial Ownership (4)
06/16/201518:21:12Initial Statement of Beneficial Ownership (3)
06/16/201518:11:30Initial Statement of Beneficial Ownership (3)
06/16/201510:37:15Abbott Labs to Vote in Favor of Mylan's Perrigo Deal
06/16/201509:19:00Mylan Issues Statement in Response to Abbott's Support for Perrigo...
06/16/201509:00:00Abbott Affirms its Support for Mylan Standalone Strategy and...
06/12/201510:28:00Abbott Declares 366th Consecutive Quarterly Dividend
06/11/201512:05:033 Things AbbVie Inc.'s Management Wants You to Know
06/05/201518:06:37Statement of Changes in Beneficial Ownership (4)

Abbott Laboratories and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations